Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03504644
Title Venetoclax and Vincristine Liposomal in Treating Patients With Relapsed or Refractory T-cell or B-cell Acute Lymphoblastic Leukemia
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors ECOG-ACRIN Cancer Research Group

acute lymphoblastic leukemia


Venetoclax + Vincristine Sulfate

Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Yale University Recruiting New Haven Connecticut 06520 United States Details
Northwestern University Recruiting Chicago Illinois 60611 United States Details
Mayo Clinic in Rochester Recruiting Rochester Minnesota 55905 United States Details
Rutgers Cancer Institute of New Jersey Recruiting New Brunswick New Jersey 08903 United States Details
Memorial Sloan Kettering Cancer Center Recruiting New York New York 10065 United States Details
Penn State Milton S Hershey Medical Center Recruiting Hershey Pennsylvania 17033-0850 United States Details
University of Pennsylvania/Abramson Cancer Center Recruiting Philadelphia Pennsylvania 19104 United States Details
Thomas Jefferson University Hospital Recruiting Philadelphia Pennsylvania 19107 United States Details
Medical College of Wisconsin Recruiting Milwaukee Wisconsin 53226 United States Details
*Shaded cells indicate that there was no data available from for the field